These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 20979814

  • 1. [The expression of O6-methylguanine DNA methyltransferase and p53 in non-small cell lung cancer and the association with the prognosis].
    Liu Y, Wang J, Zhang H, Fu XM, Wang HQ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):427-31. PubMed ID: 20979814
    [Abstract] [Full Text] [Related]

  • 2. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
    Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA.
    Cancer Res; 2001 Nov 15; 61(22):8113-7. PubMed ID: 11719438
    [Abstract] [Full Text] [Related]

  • 3. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.
    Ann Surg Oncol; 2008 Nov 15; 15(11):3272-7. PubMed ID: 18712569
    [Abstract] [Full Text] [Related]

  • 4. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 5. Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer.
    Osanai T, Takagi Y, Toriya Y, Nakagawa T, Aruga T, Iida S, Uetake H, Sugihara K.
    Jpn J Clin Oncol; 2005 Mar 14; 35(3):121-5. PubMed ID: 15741301
    [Abstract] [Full Text] [Related]

  • 6. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 14; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.
    Miyatake K, Gemba K, Ueoka H, Nishii K, Kiura K, Tabata M, Shibayama T, Takigawa N, Kawaraya M, Tanimoto M.
    Anticancer Res; 2003 Mar 14; 23(3C):2829-36. PubMed ID: 12926120
    [Abstract] [Full Text] [Related]

  • 8. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
    Kim JI, Suh JT, Choi KU, Kang HJ, Shin DH, Lee IS, Moon TY, Kim WT.
    Hum Pathol; 2009 Jul 14; 40(7):934-41. PubMed ID: 19356788
    [Abstract] [Full Text] [Related]

  • 9. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Srivenugopal KS, Shou J, Mullapudi SR, Lang FF, Rao JS, Ali-Osman F.
    Clin Cancer Res; 2001 May 14; 7(5):1398-409. PubMed ID: 11350911
    [Abstract] [Full Text] [Related]

  • 10. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul 14; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 11. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G.
    Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
    Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, Bocklage TJ, Belinsky SA.
    Cancer Res; 2003 Aug 15; 63(16):4842-8. PubMed ID: 12941804
    [Abstract] [Full Text] [Related]

  • 14. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.
    Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe N, Schneider S, Hölscher AH, Danenberg KD, Danenberg PV.
    Clin Cancer Res; 2003 Jan 15; 9(1):223-7. PubMed ID: 12538473
    [Abstract] [Full Text] [Related]

  • 15. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
    Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, Baylin SB, Herman JG.
    Cancer Res; 2001 Jun 15; 61(12):4689-92. PubMed ID: 11406538
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC, Lam SY, Tsang KW, Lam B, Ho JC, Fu KH, Lam WK, Kwong YL.
    Clin Cancer Res; 2002 Dec 15; 8(12):3741-6. PubMed ID: 12473584
    [Abstract] [Full Text] [Related]

  • 18. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 15; 13(6):967-75. PubMed ID: 15184253
    [Abstract] [Full Text] [Related]

  • 19. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.